搜索临床试验以:YY-20394
总计32个结果
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知套细胞淋巴瘤 | 边缘区淋巴瘤 | 淋巴浆细胞性淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 小淋巴细胞淋巴瘤
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知
-
Ruijin HospitalTianjin Medical University Cancer Institute and Hospital尚未招聘
-
Shanghai YingLi Pharmaceutical Co. Ltd.招聘中
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知
-
Shanghai YingLi Pharmaceutical Co. Ltd.尚未招聘Effectiveness,Safety,Thymic Cancer
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知弥漫性大 B 细胞淋巴瘤
-
University of CopenhagenEC-FP6 (contract number: LHM-CT-2003-503041); Aditech Pharma AB完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Beijing Tongren Hospital招聘中T淋巴母细胞淋巴瘤 | 自然杀伤/T 细胞淋巴瘤,鼻腔和鼻腔型中国
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中转移性结直肠腺癌 | IV 期结直肠癌 AJCC v8 | III 期结直肠癌 AJCC v8 | 转移性微卫星稳定性结直肠癌 | 晚期微卫星稳定性结直肠癌 | 晚期结直肠腺癌美国
-
University of Sao Paulo General Hospital招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI)尚未招聘
-
Tibotec Pharmaceuticals, Ireland撤销
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中转移性结直肠腺癌 | 转移性结肠腺癌 | 转移性直肠腺癌 | IV 期结肠癌 AJCC v8 | IV 期结直肠癌 AJCC v8 | IV 期直肠癌 AJCC v8 | 转移性微卫星稳定性结直肠癌美国